Ковид лечение
ВОЗ - китайские проститутки. Не надо их читать. Последние обзоры эффективности ивермектина:
1. Global trends in clinical studies of ivermectin in COVID-1...
Furthermore, by the 27th of February, the results of 42 clinical trials, including approximately 15,000 patients (both registered and unregistered studies) have been subjected to a meta-analysis after exclusion of biasing factors. It was found that 83% showed improvements with early treatment, 51% improved during late-stage treatment, and there was an 89% prevention of onset rate noted. This confirms the usefulness of ivermectin. Since it is a meta-analysis based on 42 test results, it is estimated that the probability of this comprehensive judgment being a mistake is as low as 1 in 4 trillion.
В 6 раз выше эффективность на ранних стадиях, в 2 раза ниже смертность на поздних стадиях, в 9 раз ниже заболеваемость при профилактике.
2. Ivermectin for Prevention and Treatment of COVID-19 Infect...
Twenty-one RCTs involving 2741 participants met review inclusion. Meta-analysis of 13 trials found ivermectin reduced risk of death compared with no ivermectin (average Risk Ratio 0.32, 95% con¦dence interval (CI) 0.14 to 0.72; n=1892; I2=57%; low to moderate-certainty evidence. Low-certainty evidence found ivermectin prophylaxis reduced covid-19 infection by an average 86% (95% CI 79% to 91%).
То есть в 3 раза сокращает смертность, в 7 раз заболеваемость, но мы будем делать вид, что это всё фигня.
3. Ivermectin reduces the risk of death from COVID-19 -a rapi...
Moderate certainty evidence indicates that ivermectin probably reduces deaths by an average 83% (95% CI, 65% to 92%) compared with no ivermectin treatment (5 RCTs, 1107 participants; RR 0.17, 95% 0.08 to 0.35; risk of death 1.4% versus 8.4% among participants in this analysis).
Moderate certainty evidence suggests that ivermectin prophylaxis among health care workers and COVID-19 contacts probably reduces the risk of COVID-19 infection by about 88% (4 studies, 851 participants; RR 0.12, 95% CI 0.08 to 0.18; 4.3% vs 34.5% contracted COVID-19).
Смертность уменьшается в 6 раз, заболеваемость в 9 раз.
4. Review of the Emerging Evidence Demonstrating the Efficacy ...
